Perfusion Systems Market Size, Trends and Growth Analysis by 2027

The global market for perfusion systems is projected to grow from US$ 1,044.75 million in 2018 to US$ 1,442.28 million by 2027, reflecting a compound annual growth rate (CAGR) of 3.8% from 2019 to 2027.

The expansion of the perfusion systems market can be largely attributed to the increasing incidence of cardiovascular diseases, the robust growth of the pharmaceutical and biotechnology sectors, a heightened demand for organ transplants, and an upsurge in cell-based research initiatives. Nevertheless, the high costs associated with organ transplant procedures and the limited availability of organ donors may hinder market growth. Conversely, emerging markets present significant growth opportunities that could positively influence the global perfusion systems market in the near future. Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, affecting a larger population than any other health condition. Factors such as lifestyle choices and the natural aging process contribute to the higher susceptibility of older adults to these diseases. The aging demographic often experiences structural and functional changes in blood vessels over time, which elevates the risk of developing cardiovascular conditions. Consequently, the global prevalence of cardiovascular diseases is on the rise.

Several key factors contribute to the incidence of cardiovascular diseases among various populations. According to the American College of Cardiology, CVD is responsible for nearly 800,000 deaths annually in the United States, equating to approximately one in every three deaths. Coronary heart disease (CHD) accounts for the majority of these fatalities, followed by stroke and heart failure. Over 90 million Americans are diagnosed with some form of CVD. On a global scale, cardiovascular diseases are responsible for around 31% of all deaths, with projections indicating that the economic burden of CVD could reach approximately US$ 1,044 billion by 2030.

In 2018, the bioreactor segment of the perfusion systems market commanded the largest share, accounting for 44.3% of the total market by type. This segment is expected to maintain its leading position through 2027, driven by increased production in the biopharmaceutical and pharmaceutical industries, as well as its advantages such as high product quality, stability, and scalability. Additionally, the microfluidic perfusion systems segment is anticipated to experience a notable growth rate of 3.9% during the forecast period from 2019 to 2027, primarily due to its applications at the point of care.

The global perfusion systems market is categorized by components, which include oxygenators, heart-lung machines, perfusion pumps, monitoring systems, cannulas, and others. The oxygenators segment is projected to grow at a CAGR of 4.4% throughout the forecast period. The rising number of cardiovascular surgeries, along with liver and kidney transplants worldwide, is expected to drive the growth and prominence of this segment. The oxygenators segment is also likely to demonstrate the highest growth, showcasing a strong CAGR over the coming years.

Key primary and secondary sources utilized in the report on perfusion systems include organizations such as the Australasian Board of Cardiovascular Perfusion, the Board of Cardiovascular Perfusion India, the China Food & Drug Administration, various contract research organizations, the Food and Drug Administration, and the New Mexico Asthma Control Program, among others.